IMIGRAN

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug IMIGRAN contains one active pharmaceutical ingredient (API):

1	Sumatriptan UNII J8BDZ68989 - SUMATRIPTAN SUCCINATE
	Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction.
	Read more about Sumatriptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IMIGRAN Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
IMIGRAN Nasal spray, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
IMIGRAN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CC01	Sumatriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10694W, 1849H, 8144P, 8341B, 8885P
BR	Câmara de Regulação do Mercado de Medicamentos	510603801111310, 510603802116316
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00686256, 00686279, 00686322, 00686411, 00839211, 07275042, 07320593
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	H4150413, H4160413
EE	Ravimiamet	1024771, 1139880, 1139891, 1139903, 1139914, 1139936, 1139947, 1680577
ES	Centro de información online de medicamentos de la AEMPS	59973, 61629, 61630, 66406
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005958, 013597, 013608, 018782, 018787, 018793, 018798, 018831, 018920, 093252, 093260, 198747, 411918, 415422
GB	Medicines & Healthcare Products Regulatory Agency	139154, 139158, 142500, 142502, 142506, 142510, 142513, 161901, 161903, 161905, 161910, 161912, 161914, 161916, 161918, 175622, 18519, 18546, 196146, 198745, 198747, 27747, 34890, 34891, 368034, 368036, 368038, 374175, 376553, 377200, 377202, 381401, 392150, 394069, 43703, 47897, 94846, 94849
HK	Department of Health Drug Office	39285
HR	Agencija za lijekove i medicinske proizvode	HR-H-584958851
IE	Health Products Regulatory Authority	29002, 29059, 29118, 29136, 29220, 29253, 30633, 30644, 32060, 32061, 32062, 36555
IT	Agenzia del Farmaco	027975059, 027975061, 027975073
JP	医薬品医療機器総合機構	2160003F1022, 2160402G1026
LT	Valstybinė vaistų kontrolės tarnyba	1003053, 1003055, 1003058, 1004663, 1004664, 1074067, 1074068, 1074069, 1074070
MT	Medicines Authority	MA192/04001
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	096M92, 568M95
NL	Z-Index G-Standaard	13783149, 13784129
NL	Z-Index G-Standaard, PRK	38210, 45845, 62359, 67679, 79480, 79499
NZ	Medicines and Medical Devices Safety Authority	5569
PL	Rejestru Produktów Leczniczych	100030311, 100030328, 100078000, 100101229, 100164690, 100164709
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64946001, W64946002, W64946003, W64946004, W64946005, W64948001, W64948002, W64948003, W64948004, W64948005
SG	Health Sciences Authority	06744P, 08419P
TN	Direction de la Pharmacie et du Médicament	14263011, 24833021
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522092895, 8699522092901, 8699522092918, 8699522099276, 8699522952922, 8699522952939
ZA	Health Products Regulatory Authority	28/7.3/0726, 31/7.3/0197, Z/7.3/11, Z/7.3/12